Differences

This shows you the differences between two versions of the page.

--- pharmaceutical_companies:abcellera [2023/10/20 13:16]
pamela [Eli Lilly]
+++ pharmaceutical_companies:abcellera [2024/03/08 16:46] (current)
liam
@@ Line 4: / Line 4: @@
 **AbCellera** is a Canadian biotechnology company based in [[:canada:british_columbia:Vancouver]], [[:canada:British Columbia]].
+==== About ====
+AbCellera grew out of the idea that single-cell [[:microfluidics]] and next-generation technologies can radically change how we discover drugs. But this isn’t just about having advanced technology. It comes from building a world-class group of innovators.
+Our multidisciplinary team of cell biologists, biochemists, engineers, data scientists, machine learning experts, and business professionals is working on some of the toughest areas of disease. We push the limits of antibody discovery to help partners tackle the world’s most urgent medical challenges.
+Our impact is measured by the success of our partners and the advancement of [[:antibody therapies]]. We are motivated by the feeling that our days are being well spent. That our work really matters.((https://web.archive.org/web/20230209020546/https://abcellera.com/team/))
 ===== Affiliations =====
@@ Line 27: / Line 35: @@
 ==== DARPA ====
-In 2018, AbCellera received US$30.6 million from the Defense Advanced Research Projects Agency ([[:DARPA]]) to lead one of four research groups aimed at developing antibody treatments for pandemics.((Silcoff, S. (2020, December 11). //A Canadian biotech giant is born: AbCellera stock triples in debut, company now worth US$15-billion.// The Globe and Mail. https://archive.ph/Qk1Ay)) ((Weirich, A. (2020, January 28). //AbCellera is mobilizing a response to the novel coronavirus outbreak as part of its DARPA P3 program.// AbCellera. https://archive.ph/WvZkz)) ((Heyries, K. (2018, March 13). //AbCellera Awarded Multi-Year Contract to Lead the Development of a Rapid Response Platform Against Pandemic Viral Threats.// AbCellera. https://archive.ph/joDOD))
+In 2018, AbCellera received US$30.6 million from the [[:Defense Advanced Research Projects Agency]] ([[:DARPA]]) to lead one of four research groups aimed at developing antibody treatments for pandemics.((Silcoff, S. (2020, December 11). //A Canadian biotech giant is born: AbCellera stock triples in debut, company now worth US$15-billion.// The Globe and Mail. https://archive.ph/Qk1Ay)) ((Weirich, A. (2020, January 28). //AbCellera is mobilizing a response to the novel coronavirus outbreak as part of its DARPA P3 program.// AbCellera. https://archive.ph/WvZkz)) ((Heyries, K. (2018, March 13). //AbCellera Awarded Multi-Year Contract to Lead the Development of a Rapid Response Platform Against Pandemic Viral Threats.// AbCellera. https://archive.ph/joDOD))
 ==== Eli Lilly ====
@@ Line 67: / Line 75: @@
 Mr. Woersching has served as a member of our Board of Directors since June 2022. Mr. Woersching currently serves as a private consultant for early stage software companies, where he focuses on corporate strategy, FP&A, analytics, operations and executive recruiting. From 2020 to 2022, Mr. Woersching served as the Vice President of Revenue Operations at [[:EasyPost]], where he was responsible for analytics, operations and corporate strategy, and Senior Advisor to the CEO, where he focused on corporate development, M&A and fundraising. From 2017 to 2019, Mr. Woersching was a general partner at [[:Initialized Capital]], a venture capital firm, where he served on the board of directors of several private technology companies. He holds both a B.S. and M.S. in Electrical Engineering from [[:Stanford]] University and is a Chartered Financial Analyst.((https://web.archive.org/web/20210421004846/https://investors.palantir.com/governance/board-of-directors))
+==== NEWS ====
+Peter Thiel joins board of antibody therapy developer AbCellera
+Reuters - November 19, 2020
+(Reuters) - Billionaire venture capitalist [[:Peter Thiel]] has joined AbCellera Biologics Inc’s board of directors, the Canadian antibody therapy developer said on Thursday.
+Thiel, who has backed several startups as they went public, is an existing investor in AbCellera. He joins the startup’s board a couple of months after Reuters reported that it had hired investment banks for a U.S. initial public offering, which could come this year.
+AbCellera has been working with [[:Eli Lilly]] and Co LLY.N to **develop a treatment for the novel coronavirus**.
+Thiel is known for his early investments in [[:Facebook]] FB.O and co-founding electronic payment service provider [[:Paypal]] Inc PYPL.O. In September, he took data analytics firm [[:Palantir]] Technologies Inc PLTR.N public through a direct-listing.((https://web.archive.org/web/20201119202941/https://www.reuters.com/article/us-abcellera-board-thiel/peter-thiel-joins-board-of-antibody-therapy-developer-abcellera-idUSKBN27Z2J3))
+===== External links =====
+  * [[https://wiki.whiteroseintelligence.com/en/AbCellera|White Rose Wiki]]